Citric acid-based hydroxyapatite composite scaffolds enhance calvarial regeneration

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Sun, Dawei ^a,b   Chen, Yuhui ^a   Tran, Richard T ^c   Xu, Song ^a,d   Xie, Denghui ^a,c   Jia, Chunhong ^d   Wang, Yuchen ^a   Guo, Ying ^a   Zhang, Zhongmin ^a   Guo, Jinshan ^c   Yang, Jian ^c   Jin, Dadi ^a   Bai, Xiaochun ^a,d  

^a THE THIRD AFFILIATED HOSPITAL OF SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGDONG SECOND PROVINCIAL GENERAL HOSPITAL   (China)

^c The Pennsylvania State University   (United States)

^d SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; CITRIC ACID; HYDROXYAPATITE; POLY(1,8-OCTANEDIOL CITRATE); POLYESTER; POLYMER; URETHAN;

ANGIOGENESIS; ANIMAL; AUTOTRANSPLANTATION; BONE DENSITY; BONE REGENERATION; BONE TRANSPLANTATION; CHEMISTRY; INJURIES; MALE; PHYSIOLOGY; POROSITY; RAT; SKULL; SPRAGUE DAWLEY RAT; SURGERY; TISSUE ENGINEERING; TISSUE SCAFFOLD; VASCULARIZATION;

ANIMALS; BIOCOMPATIBLE MATERIALS; BONE DENSITY; BONE REGENERATION; BONE TRANSPLANTATION; CITRATES; CITRIC ACID; DURAPATITE; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; POLYESTERS; POLYMERS; POROSITY; RATS; RATS, SPRAGUE-DAWLEY; SKULL; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TRANSPLANTATION, AUTOLOGOUS; URETHANE;

EID: 84923233784     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep06912     Document Type: Article

References (53)

1. Giannoudis, P. V., Dinopoulos, H. & Tsiridis, E. Bone substitutes: an update. Injury 36 Suppl 3, S20-27 (2005).
2. Watson, J. T. Overview of biologics. J. Orthop. Trauma. 19, S14-16 (2005).
3. Friedlander, A. H. The physiology, medical management and oral implications of menopause. J. Am. Dent. Assoc. 133, 73-81 (2002).
4. Bauer, T. W. & Muschler, G. F. Bone graft materials. An overview of the basic science. Clin. Orthop. Relat. R. 371, 10-27 (2000).
5. Acarturk, T. O. & Hollinger, J. O. Commercially available demineralized bone matrix compositions to regenerate calvarial critical-sized bone defects. Plast. Reconstr. Srug. 118, 862-873 (2006).
6. Parikh, S. N. Bone graft substitutes: past, present, future. J. Postgrad. Med 48, 142-148 (2002).
7. Carson, J. S. & Bostrom,M. P. Synthetic bone scaffolds and fracture repair. Injury 38 Suppl 1, S33-37 (2007).
8. Damien, C. J. & Parsons, J. R. Bone graft and bone graft substitutes: a review of current technology and applications. J. Appl. Biomater. 2, 187-208 (1991).
9. Lane, J. M., Tomin, E. & Bostrom, M. P. Biosynthetic bone grafting. Clin. Orthop Relat. R. 367 Suppl, S107-117 (1999).
10. Bohner, M. Calcium orthophosphates in medicine: from ceramics to calcium phosphate cements. Injury 31 Suppl 4, 37-47 (2000).
11. Acharya, B. et al. Surface immobilization of MEPE peptide onto HA/beta-TCP ceramic particles enhances bone regeneration and remodeling. J. Biomed. Mater. Res. B. 100, 841-849 (2012).
12. Bucholz, R. W. Nonallograft osteoconductive bone graft substitutes. Clin. Orthop Relat. R. 395, 44-52 (2002).
13. Liu, H. & Webster, T. J. Mechanical properties of dispersed ceramic nanoparticles in polymer composites for orthopedic applications. Int. J. Nanomed. 5, 299-313 (2010).
14. Wagoner Johnson, A. J. & Herschler, B. A. A review of the mechanical behavior of CaP and CaP/polymer composites for applications in bone replacement and repair. Acta. Biomater. 7, 16-30 (2011).
15. Zioupos, P., Gresle, M. &Winwood, K. Fatigue strength of human cortical bone: age, physical, and material heterogeneity effects. J. Biomed. Mater. Res. A. 86, 627-636 (2008).
16. Hu, Y. Y., Rawal, A. & Schmidt-Rohr, K. Strongly bound citrate stabilizes the apatite nanocrystals in bone. P. Natl. Acad. Sci. USA. 107, 22425-22429 (2010).
17. Tran, R. T. et al. Synthesis and characterization of biomimetic citrate-based biodegradable composites. J. Biomed. Mater. Res. A. 102(8), 2521-32 (2013).
18. Costello, L. C., Franklin, R. B., Reynolds, M. A. & Chellaiah, M. The Important Role of Osteoblasts and Citrate Production in Bone Formation: "Osteoblast Citration" as a New Concept for an Old Relationship. Open. Bone. J. 4, doi:10.2174/1876525401204010027 (2012).
19. Davies, E. et al. Citrate bridges between mineral platelets in bone. P. Natl. Acad. Sci. USA. 111, E1354-1363 (2014).
20. Qiu, H., Yang, J., Kodali, P., Koh, J. & Ameer, G. A. A citric acid-based hydroxyapatite composite for orthopedic implants. Biomaterials 27, 5845-5854 (2006).
21. Dey, J. et al. Development of biodegradable crosslinked urethane-doped polyester elastomers. Biomaterials 29, 4637-4649 (2008).
22. Yang, J. et al. Development of aliphatic biodegradable photoluminescent polymers. P. Natl. Acad. Sci. USA. 106, 10086-10091 (2009).
23. Gyawali, D. et al. Fluorescence imaging enabled biodegradable photostable polymeric micelles. Adv. Healthc. Mater. 3, 182-186 (2014).
24. Tran, R. T. et al. Synthesis and characterizaion of a biodegradable elastomer featuring a dual crosslinking mechanism. Soft. Matter. 6, 2449-2461 (2010).
25. Gyawali, D., Tran, R. T., Guleserian, K. J., Tang, L. & Yang, J. Citric-acid-derived photo-cross-linked biodegradable elastomers. J. Biomat. Sci-polym. E. 21, 1761-1782 (2010).
26. Guo, J. et al. Click Chemistry Plays a Dual Role in Biodegradable Polymer Design. Adv. Mater. 26, 1906-1911 (2013).
27. Dey, J., Xu, H., Nguyen, K. & Yang, J. Crosslinked urethane doped polyester (CUPE) biphasic scaffolds: potential for in vivo vascular tissue engineering. J. Biomed. Mater. Res. A. 95A, 361-370 (2010).
28. Tran, R. T. et al. Fabrication and characterization of biomimetic multichanneled crosslinked-urethane doped polyester nerve guides. J. Biomed. Mater. Res. A. 102(8), 2793-804 (2014).
29. Wadajkar, A. S. et al. Dual-imaging enabled cancer-targeting nanoparticles. Adv. Healthc. Mater. 1, 450-456 (2012).
30. Sicchieri, L. G., Crippa, G. E., de Oliveira, P. T., Beloti, M. M. & Rosa, A. L. Pore size regulates cell and tissue interactions with PLGA-CaP scaffolds used for bone engineering. J. Tissue. Eng. Regen M. 6, 155-162 (2012).
31. Hartles, R. L. Citrate in Mineralized Tissues. Adv. Oral. Biol. 1, 225-253 (1964).
32. Yang, J., Webb, A. & Ameer, G. Novel citric acid-based biodegradable elastomers for tissue engineering. Adv. Mater. 16, 511-516 (2004).
33. Dickens, F. The citric acid content of animal tissues, with reference to its occurrence in bone and tumour. Biochem. J. 35, 1011-1023 (1941).
34. Senn on the Healing of Aseptic Bone Cavities by Implantation of Antiseptic Decalcified Bone. Ann. Surg. 10, 352-368 (1889).
35. Schmitz, J. P. & Hollinger, J. O. The critical size defect as an experimental model for craniomandibulofacial nonunions. Clin. Orthop. Relat. R. 205, 299-308 (1986).
36. Fini, M. et al. The healing of confined critical size cancellous defects in the presence of silk fibroin hydrogel. Biomaterials 26, 3527-3536 (2005).
37. Schmitz, J. P., Schwartz, Z., Hollinger, J. O. & Boyan, B. D. Characterization of rat calvarial nonunion defects. Acta. Anat. 138, 185-192 (1990).
38. Dupoirieux, L., Pourquier, D., Picot, M. C. & Neves, M. Comparative study of three different membranes for guided bone regeneration of rat cranial defects. Int. J. Oral. Max. Surg. 30, 58-62 (2001).
39. Prolo, D. J., Gutierrez, R. V., DeVine, J. S. & Oklund, S. A. Clinical utility of allogeneic skull discs in human craniotomy. Neurosurgery 14, 183-186 (1984).
40. Sirola, K. Regeneration of defects in the calvaria. An experimental study. Ann. Med. Exp. Biol. Fenn. 38 (Suppl 2), 1-87 (1960).
41. Cutting, C. B., McCarthy, J. G. & Berenstein, A. Blood supply of the upper craniofacial skeleton: the search for composite calvarial bone flaps. Plastic. Reconstr. Surg. 74, 603-610 (1984).
42. Greenwald, A. S. et al. Bone-graft substitutes: facts, fictions, and applications. J. Bone. Joint. Surg. Am. 83-A Suppl 2 Pt 2, 98-103 (2001).
43. Liu, X. et al. Vascularized bone tissue formation induced by fiber-reinforced scaffolds cultured with osteoblasts and endothelial cells. Biomed. Res. Int. 2013, 854917 (2013).
44. Jane, E. A. [Mesenchymal Stem Cell and Osteoblast Differentiation] Principles of Bone Biology. Volume 1. [John P. B., Lawrence G. R., & T, J. M. (3ed.)] [85-108] (Elsevier, Amsterdam, 2008).
45. Willems, W. F., Kremer, T., Friedrich, P. & Bishop, A. T. Surgical Revascularization in Structural Orthotopic Bone Allograft Increases Bone Remodeling. Clin. Orthop. Relat. R. 472(9), 2870-7 (2014).
46. Vunjak-Novakovic, G. et al. Dynamic cell seeding of polymer scaffolds for cartilage tissue engineering. Biotechnol. Progr. 14, 193-202 (1998).
47. Ozturk, B. Y. et al. The treatment of segmental bone defects in rabbit tibiae with vascular endothelial growth factor (VEGF)-loaded gelatin/hydroxyapatite "cryogel" scaffold. Eur. J. Orthop. Surg. Tr. 23, 767-774 (2013).
48. Han, F. et al. Performance of amultilayered small-diameter vascular scaffold dualloaded with VEGF and PDGF. Biomaterials 34, 7302-7313 (2013).
49. Ahlmann, E., Patzakis, M., Roidis, N., Shepherd, L. & Holtom, P. Comparison of anterior and posterior iliac crest bone grafts in terms of harvest-site morbidity and functional outcomes. J. Bone. Joint. Surg. Am. 84-A, 716-720 (2002).
50. Oakley, M. J., Smith, W. R., Morgan, S. J., Ziran, N. M. & Ziran, B. H. Repetitive posterior iliac crest autograft harvest resulting in an unstable pelvic fracture and infected non-union: case report and review of the literature. Patient. Saf. Surg. 1(1), 6 (2007).
51. Langer, R. & Vacanti, J. P. Tissue engineering. Science 260, 920-926 (1993).
52. Marx, V. Cell culture: a better brew. Nature 496, 253-258 (2013).
53. Griffith, L. G. & Swartz, M. A. Capturing complex 3D tissue physiology in vitro. Nature. Rev. Mol. Cell. Bio. 7, 211-224 (2006).